Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Probiotics to reduce antibiotic administration in care home residents aged 65 years and older: the PRINCESS RCT

Title: Probiotics to reduce antibiotic administration in care home residents aged 65 years and older: the PRINCESS RCT
Authors: Butler, CC; Owen-Jones, E; Lau, M; Gillespie, D; Lown, M; Calder, PC; Stanton, H; Wootton, M; Castro Herrera, V; Bayer, A; Davies, J; Edwards, A; Davoudianfar, M; Rutter, H; Hood, K; Moore, M; Little, P; Shepherd, V; Lowe, R; Miles, EA; Townson, J; Hobbs, FDR; Francis, NA
Publisher Information: National Institute for Health Research
Publication Year: 2021
Collection: Oxford University Research Archive (ORA)
Description: Background Care homes are an increasingly important sector of care. Care home residents are particularly vulnerable to infections and are often prescribed antibiotics, driving antibiotic resistance. Probiotics may be a cheap and safe way to reduce antibiotic use. Efficacy and possible mechanisms of action are yet to be rigorously evaluated in this group. Objective The objective was to evaluate efficacy and explore mechanisms of action of a daily oral probiotic combination in reducing antibiotic use and infections in care home residents. Design This was a multicentre, parallel, individually randomised, placebo-controlled, double-blind trial, with qualitative evaluation and mechanistic studies. Setting A total of 310 care home residents were randomised from 23 UK care homes (from December 2016 to May 2018). Participants The participants were care home residents aged ≥ 65 years who were willing and able to give informed consent or, if they lacked capacity to consent, had a consultee to advise about participation on their behalf. Intervention A daily capsule containing an oral probiotic combination of Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12 (n = 155) or matched placebo (n = 155) for up to 1 year. Main outcome measures The primary outcome was cumulative systemic antibiotic administration days for all-cause infections. Secondary outcomes included incidence and duration of infections, antibiotic-associated diarrhoea, quality of life, hospitalisations and the detection of resistant Enterobacterales cultured from stool samples (not exclusively). Methods Participants were randomised (1 : 1) to receive capsules containing probiotic or matched placebo. Minimisation was implemented for recruiting care home and care home resident sex. Care home residents were followed up for 12 months with a review by a research nurse at 3 months and at 6–12 months post randomisation. Care home residents, consultees, care home staff and all members of the trial team, including assessors and statisticians, ...
Document Type: article in journal/newspaper
Language: English
Relation: https://doi.org/10.3310/eme08070
DOI: 10.3310/eme08070
Availability: https://doi.org/10.3310/eme08070; https://ora.ox.ac.uk/objects/uuid:28dad4dc-d6ae-419e-b049-edec48d0f8b7
Rights: info:eu-repo/semantics/openAccess ; CC Attribution (CC BY)
Accession Number: edsbas.D0AB07F7
Database: BASE